Based on ROC to explore the relationship between the changes of serum α1-AT and NE levels and the severity of AECOPD and the value of predicting respiratory failure
-
摘要: 目的 基于受试者工作特征(ROC)曲线探讨慢阻肺急性加重期(AECOPD)患者血清α1-抗胰蛋白酶(α1-AT)、嗜中性粒细胞弹性蛋白酶(NE)水平变化与病情程度间关系及预测呼吸衰竭的价值。方法 选取2018年2月-2020年2月期间我院AECOPD患者94例作为观察组,同期稳定期COPD患者44例作为对照组。比较两组血清α1-AT、NE水平及不同病情程度AECOPD患者血清α1-AT、NE水平,分析AECOPD患者血清α1-AT、NE水平与病情程度相关性,logistic回归分析AECOPD并发呼吸衰竭的影响因素,ROC曲线分析血清α1-AT、NE水平对AECOPD并发呼吸衰竭的预测价值。结果 观察组血清α1-AT、NE水平高于对照组(P < 0.05);随AECOPD病情程度增加,血清α1-AT、NE水平逐渐升高(P < 0.05);AECOPD患者血清α1-AT、NE水平与病情程度相关性呈正相关关系(P < 0.05);AECOPD并发呼吸衰竭患者血清α1-AT、NE水平高于未并发呼吸衰竭患者(P < 0.05);logistic回归分析显示,血清α1-AT、NE水平升高均为AECOPD并发呼吸衰竭的危险因素(P < 0.05);ROC曲线显示,血清α1-AT、NE联合预测AECOPD并发呼吸衰竭的AUC值0.841最大,对应敏感度为72.73%,特异度为85.25%。结论 AECOPD患者血清α1-AT、NE表达明显升高,与病情程度呈正相关,且血清α1-AT、NE水平与AECOPD患者发生呼吸衰竭有关,通过测定其水平可有效预测呼吸衰竭发生风险,为临床治疗提供指导。
-
关键词:
- 慢阻肺急性加重期 /
- α1-抗胰蛋白酶 /
- 嗜中性粒细胞弹性蛋白酶 /
- 病情程度 /
- 呼吸衰竭
Abstract: Objective To explore the relationship between the changes in serum α1-antitrypsin (α1-AT) and neutrophil elastase (NE) levels and the severity of the disease in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and predicting the value of respiratory failure based on the receiver operating characteristic (ROC) curve.Methods From February 2018 to February 2020, 94 patients with AECOPD in our hospital were selected as the observation group, and 44 patients with stable COPD were selected as the control group during the same period. The levels of serum α1-AT and NE in the two groups and the levels of serum α1-AT and NE in patients with different degrees of AECOPD were compared. The correlation between serum α1-AT and NE levels and the degree of AECOPD was analyzed. logistic regression was used to analyze the influencing factors of AECOPD complicated with respiratory failure. The receiver operating characteristic (ROC) curve was used to analyze the predictive value of serum α1-AT and NE levels for AECOPD complicated with respiratory failure.Results The serum levels of α1-AT and NE in the observation group were higher than those in the control group (P<0.05).Serum α1-AT and NE levels gradually increased with the increase of AECOPD severity (P < 0.05). The serum levels of α1-AT and NE were positively correlated with the severity of AECOPD (P<0.05).The serum levels of α1-AT and NE in AECOPD patients complicated with respiratory failure were higher than those without respiratory failure (P<0.05). logistic regression analysis showed that elevated serum levels of α1-AT and NE were risk factors for AECOPD complicated with respiratory failure (P<0.05).The ROC curve showed that serum α1-AT and NE combined to predict AECOPD complicated with respiratory failure had the highest AUC value of 0.841, corresponding sensitivity of 72.73% and specificity of 85.25%.Conclusion The expression of serum α1-AT and NE in AECOPD patients is significantly increased, which is positively correlated with the severity of the disease, and the serum α1-AT and NE levels are related to the occurrence of respiratory failure in patients with AECOPD. The determination of serum α1-AT and NE levels can effectively predict the risk of respiratory failure and provide guidance for clinical treatment. -
表 1 两组血清α1-AT、NE水平对比
x±S 组别 例数 α1-AT/(mg·L-1) NE/(μg·L-1) 观察组 94 10.37±2.21 249.84±39.86 对照组 44 6.14±1.58 124.38±24.37 t 11.396 19.241 P < 0.001 < 0.001 表 2 不同病情程度AECOPD患者血清α1-AT、NE水平
x±S 病情程度 例数 α1-AT/(mg·L-1) NE/(μg·L-1) 轻度 32 8.25±1.86 206.52±36.08 中度 36 10.29±2.17 247.37±35.72 重度 26 13.09±2.39 306.58±46.87 F 36.857 46.815 P < 0.001 < 0.001 表 3 AECOPD并发呼吸衰竭的单因素分析
例(%),x±S 相关因素 并发呼吸衰竭(33例) 未并发呼吸衰竭(61例) t/χ2 P 性别 男 21(63.64) 41(67.21) 0.122 0.727 女 12(36.36) 20(32.79) 年龄/岁 < 60 9(27.27) 32(52.46) 5.524 0.019 ≥60 24(72.73) 29(47.54) 病程/年 < 10 8(24.24) 34(55.74) 8.594 0.003 ≥10 25(75.76) 27(44.26) 肺功能 FEV1/L 0.91±0.27 1.17±0.35 3.709 < 0.001 FVC/L 1.71±0.38 2.13±0.42 4.781 < 0.001 α1-AT/(mg·L-1) 12.31±3.09 9.32±2.41 5.190 < 0.001 NE/(μg·L-1) 271.56±41.86 238.09±33.42 4.235 < 0.001 表 4 AECOPD并发呼吸衰竭的多因素分析
相关因素 β S.E. Wald χ2 P OR 95%CI α1-AT 1.552 0.497 9.752 < 0.001 4.721 3.257~6.843 NE 1.493 0.512 8.497 < 0.001 4.448 2.815~7.029 赋值:α1-AT、NE水平以均值为界, < 均值赋值为1,≥均值赋值为2 表 5 血清α1-AT、NE水平对AECOPD并发呼吸衰竭的预测价值
指标 AUC 95%CI Z P cut-off值 敏感度/% 特异度/% α1-AT 0.758 0.659~0.840 4.577 < 0.001 >10.31 μg/mL 72.73 73.77 NE 0.712 0.610~0.801 3.693 < 0.001 >257.17 ng/mL 67.58 78.69 联合 0.841 0.751~0.908 7.847 < 0.001 72.73 85.25 -
[1] Miao TW, Xiao W, Du LY, et al. High expression of SPP1 in patients with chronic obstructive pulmonary disease(COPD)is correlated with increased risk of lung cancer[J]. FEBS Open Bio, 2021, 11(4): 1237-1249. doi: 10.1002/2211-5463.13127
[2] He F, Zhao P, Chu Y, et al. Red blood cell distribution width and serum CA-125 level as prognostic markers in acute exacerbation of chronic obstructive pulmonary disease[J]. J Int Med Res, 2021, 49(5): 3000605211020229.
[3] Yan K, Wang Y, Lu Y, et al. Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome[J]. J Immunol Res, 2021, 2021(3): 1-15.
[4] Mustafa Z, Zhanapiya A, Kalbacher H, et al. Neutrophil Elastase and Proteinase 3 Cleavage Sites Are Adjacent to the Polybasic Sequence within the Proteolytic Sensitive Activation Loop of the SARS-CoV-2 Spike Protein[J]. ACS Omega, 2021, 6(10): 7181-7185. doi: 10.1021/acsomega.1c00363
[5] 刘凌, 徐红帅, 赵俊玲. α1-抗胰蛋白酶、CXCL12、IL-15Rα与艾滋病病毒感染患者预后的相关性分析[J]. 安徽医科大学学报, 2022, 57(1): 153-156. https://www.cnki.com.cn/Article/CJFDTOTAL-YIKE202201029.htm
[6] 聂晓红, 熊曙光, 王晓虹, 等. 体质量指数对慢性阻塞性肺疾病急性加重期患者治疗反应性及气道黏液高分泌的影响[J]. 中国急救医学, 2019, 39(4): 332-337. doi: 10.3969/j.issn.1002-1949.2019.04.008
[7] 滕文哲, 陈虎, 石思瑶, 等. 双水平正压通气治疗慢性阻塞性肺疾病急性加重期并发Ⅱ型呼吸衰竭效果的Meta分析与试验序贯分析[J]. 中国全科医学, 2022, 25(2): 227-235. doi: 10.12114/j.issn.1007-9572.2021.01.224
[8] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205. doi: 10.3760/cma.j.cn112147-20210109-00031
[9] 方国强, 万秋风, 田雅洁, 等. AECOPD致严重呼吸衰竭患者早期拔管后序贯经鼻高流量湿化氧疗与无创正压通气的优劣比较[J]. 中华危重病急救医学, 2021, 33(10): 1215-1220. doi: 10.3760/cma.j.cn121430-20210623-00939
[10] 李晓俊, 李亚, 卞晴晴, 等. 中西医结合治疗对慢性阻塞性肺疾病痰热证急性加重-稳定期大鼠免疫因子的影响研究[J]. 中国全科医学, 2022, 25(2): 197-205. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202202010.htm
[11] Spies R, Potter M, Hollamby R, et al. Sputum colour as a marker for bacteria in acute exacerbations of COPD: protocol for a systematic review and meta-analysis[J]. Syst Rev, 2021, 10(1): 211. doi: 10.1186/s13643-021-01767-6
[12] 蔺林, 戴飞, 任国强, 等. 嗜中性粒细胞弹性蛋白酶体外促进嗜中性粒细胞型鼻息肉中MUC5AC合成和释放[J]. 中国免疫学杂志, 2020, 36(15): 1873-1876. doi: 10.3969/j.issn.1000-484X.2020.15.017
[13] 李泉, 杜永明, 王丰. 慢性阻塞性肺疾病急性加重患者血清可溶性血红蛋白清道夫受体表达及临床意义[J]. 中国老年学杂志, 2022, 42(1): 53-55. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ202201016.htm
[14] 王莹, 范琦强, 郭松佳, 等. 缺氧条件下中介素和系膜细胞对内皮细胞血管生成的影响[J]. 中华实验外科杂志, 2022, 39(1): 45-48.
[15] 唐徐韵, 陈盼碧, 杜狄佳, 等. 穴位埋线对哮喘大鼠肺组织中p38MAPK信号通路及细胞间黏附分子-1、白细胞介素-4和嗜酸性粒细胞的影响[J]. 针刺研究, 2022, 47(2): 129-134. https://www.cnki.com.cn/Article/CJFDTOTAL-XCYJ202202006.htm
[16] Padberg F, Höper T, Henkel S, et al. Novel indirect co-culture of immortalised hepatocytes with monocyte derived macrophages is characterised by pro-inflammatory cytokine networks[J]. Toxicol In Vitro, 2021, 73: 105134. doi: 10.1016/j.tiv.2021.105134
[17] 王雪, 尹力, 高密密, 等. 肺炎支原体感染大鼠乳鼠补体激活水平及免疫因子表达[J]. 中华医院感染学杂志, 2021, 31(22): 3371-3375. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY202122003.htm
[18] 蒋伟. 人α1-抗胰蛋白酶与慢性阻塞性肺病的相关性及其作用机制的研究进展[J]. 中国生物制品学杂志, 2020, 33(11): 1317-1320. https://www.cnki.com.cn/Article/CJFDTOTAL-SWZP202011018.htm
[19] 陶静, 方晶晶, 厉旭光, 等. α1抗胰蛋白酶与脓毒症患者发生急性肾损伤的关系及其预测价值[J]. 中国现代医学杂志, 2020, 30(10): 27-32. doi: 10.3969/j.issn.1005-8982.2020.10.006
[20] 陈红波, 陈丽萍, 金永明, 等. COPD不同HRCT表型患者血清中性粒细胞弹性蛋白酶、总抗氧化能力比较[J]. 昆明医科大学学报, 2020, 41(12): 108-111. https://www.cnki.com.cn/Article/CJFDTOTAL-KMYX202012022.htm
[21] Galdi F, Pedone C, McGee CA, et al. Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study[J]. Respir Res, 2021, 22(1): 30.